ALR Technologies Announces Program for New Diabetes Health Management System
WINSTON-SALEM, NC--(Marketwire - January 30, 2008) - ALR Technologies, Inc. (OTCBB: ALRT)
announces the launching of a Diabetes Health Management System to
complement ALRT's Constant Health Companion (CHC) patient compliance
system. The System is a communications software platform that will enable
health professionals to remotely monitor the health progress specifically
relating to diabetic patients. This will facilitate more effective and
timely communication of care to these patients.
Diabetes is a leading cause of death, serious illness and disability across
North America. In the United States, it is estimated that 21 million
people have diabetes and an additional 54 million Americans have
pre-diabetes. The Canadian Diabetes Association estimates that currently
over 2 million Canadians have diabetes and this number is expected to rise
to 3 million by the end of the decade. Medical costs due to diabetes and
its complications are enormous. In the United States, such costs are
estimated to be over $130 billion a year and in Canada, healthcare costs
associated with diabetes is $13.2 billion annually.
Diabetes is a lifelong chronic disease with no cure. However, diabetics
can take steps to control their disease and reduce the risk of developing
the associated serious complications thereby controlling healthcare costs.
The Canadian Diabetes Association Clinical Practice Guidelines Expert
Committee reports that "Successful diabetes care depends on the daily
commitment of person with diabetes mellitus to self-management through the
balance of lifestyle and medication. Diabetes care should be organized
around a multi- and interdisciplinary diabetes healthcare team that can
establish and sustain a communication network between the person with
diabetes and the necessary healthcare and community systems." ALRT's
Diabetes Health Management System provides an affordable and easy to use
communication network as recommended by the Committee. (See:
A Diabetes Health Management System adapted to the Canadian market will
also be available. ERS Endocrine Research Inc. ("ERS") Vancouver, Canada
will pioneer implementation of a program in February. This will also
integrate the System in a new initiative with the newly formed Western
Canadian Insulin Pump Centres with offices in B.C. and Alberta.
In addition, ALRT is finalizing plans with a large U.S. self-insured group
for a program using the Diabetes Health Management System.
About ERS and the Western Canadian Insulin Pump Centres
ERS conducts research on new drugs and procedures. ERS has published a
number of outcome studies in both Type I and Type II diabetes. The Western
Canadian Insulin Pump Centres are dedicated to providing easy access for
patients with diabetes to insulin pump therapy. The Centres are committed
to research on the long-term utility, safety, and effectiveness of this
form of therapy.
About ALR Technologies, Inc.
ALR Technologies, Inc. (ALRT) designs and manufactures health management
compliance products and monitoring and intervention systems. ALRT's primary
system, Constant Health Companion™, fills a serious gap in standard
disease management practices. It provides for continued and affordable
compliance supervision of patients after they have left the direct care of
professionals. More information on ALR Technologies and its products can be
found at http://www.alrt.com. More information about the Constant Health
Companion can be found at: http://www.alrt.com/CHC/index.html.
This release contains certain "forward-looking statements" relating to ALR
Technologies' business, and these statements reflect the current views of
ALR Technologies with respect to future events and are subject to certain
risks, uncertainties and assumptions. When used, the words "estimate,"
"expect," "anticipate," "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors that
could cause the actual results, performance or achievements of ALR
Technologies and its products to be materially different from any future
results, performances or achievements that may be expressed or implied by
such forward-looking statements. Further management discussions of risks
and uncertainties can be found in the company's quarterly filings with the
Securities Exchange Commission.
Contact Information: Contact: